PTOiAIA/M (OB-12)
`Approved for use through 01:!31l2'014. OMB 0651-0032
`US. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1 995, no persons are required to respond to a collection ofin'forrnation unless it contains 'a valid OMB control number.
`
`
`Attorney Docket Number GWLG-O‘l YUS-ClP
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`
`
`Title Of Invention
`
`METHOD FOR DIAGNOSING AND MONITORING INFLAMMATORY DISEASE PROGRESSION
`
`
`The application data sheet ispan of'the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by theUnited States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`
`
`
`
`Secrecy Order 37 CFR 5.2
`,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
`
`Portions or all of the‘ application associated with this Application Data Sheet may fall under a secrecy Order pursuant to.
`
`
`
`37 CFR 5.2 (Paper filers only. Applications that fall underiSecrecy Order may not be filed electronically.)
`
`
`Prefix Given Name
`Middle Name
`Family Name
`Suffix-
`
`Inventor Information:
`
`
` Legal Name
`
`
`
`
`vi Warren
`Foster
`Residence Information (Select One) 0 US Residency @ Non US Residency 0 Active US Military Service
`
`
`
`
`7 ‘Country of Residence iAncasterCity CA
`
`v
`
`
`Mailing Address of Inventor:
`
`
`Address 1
`13 Landscapes Trail
`‘ Address: ‘
`
`ON
`‘ StatelProvince
`City
`i Ancaster
`Postal .Code
`:Countryi
`CA
`LQK 0A1
`
`Inventor
`2
`‘ Legal Name
`
`
`
`
`
`
`Prefix Given Name
`v Jocelyn
`Residence Information (Seléct One) 0 US Residency
`
`Middle Name
`
`i Suffix
`Family Name
`i
`.v
`Wessels
`(a) Non US Residency 0 Active US Military Service
`
`City
`Guelph
`Country of Residence
`i
`CA
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`42 Waxwing Crescent
`
`
`
`
`
`
`Address 2
`I Guelph
`City
`Postal Code
`
`L88 4K1
`
`StatelProvince
`Co‘untr'yi
`CA
`
`i ON
`
`,,,I,fl!§flt9[,,,,,,,§,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
`Legal Name
`
`
`
`EFS Web'2;2.4
`
`

`

`PTOiAIA/M (OB-12)
`Approved for use through 01:!31l2'014, OMB 0651-0032
`us. Patent and Trademark OFfice; us. DEPARTMENT OF COMMERCE
`
`Under the PaperworkReduction Act of1995, no persons are required to respond to a collectionoofinfiorma-tion unless it contains a valid OMB control number.
`
`MEl'l-IOD FOR DIAGNDSING AND MONITORING INFLAMMATORY DISEASE PROGRESSION
`Title Of Invention
`
`
`I Attorney Docket Number
`Application Data Sheet 37.CFR 1.76 .
`g
`.,
`_ g
`I Application Number
`
`GWLG-017US-CIP
`
`
`
`
`
`Prefix Given Name
`_ Middle Name
`_ Family Name
`I Suffix
`
`vi Sanjay
`Agarwal
`I
`v
`Residence Information (Select One)
`(0] US Residency 0 Non US Residency
`(3 Active US Military Service
`
`I City
`Rancho Santa Fe
`'StatelProvince
`CA
`Country of Residencé
`us
`
`
`
`
`Mailing Address of Inventor:
`
`PO Box 3831
`
`Address 1
`
`Address 2
`
`
`
`
`I City
`Rancho Santa Fe
`StatelProvince
`CA
`
`
`
`Postal Code
`92087
`Country i
`US
`Inventors Must Be Listed — Additional
`Information blocks may be,
`All
`Inventor
`
`generated within this form by selecting the Add button.
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`
`For further information'see 37 CFR 1.33(a).
`
` E An Address is being provided for the. correspondence. Information of this application.
`Customer Number I 88993
`
`
`
`Email Address p‘hiIip.zhang@mzwiplaw.com I
`
`
`
`Application Information:
`
`
`
`
`
`
`
`Title of the Invention
`METHOD FOR DIAGNOSING AND MONITORING INFLAMMATORY DISEASE PROGRESSION
`
`
`Attorney Docket Number GWLG-Ol-YUVS—CIP
`Small Entity Status Claimed E
`
`Application Type
`Nonprovisional
`v
`
`Subject Matter
`Utility
`v
`
`Suggested Class (if any)
`Sub Class (if any)
`Suggested Technology Center (if any)
`
`
`
`
`
`
`Total Number of Drawing Sheets (if any)
`I 21
`Suggested Figure for PubiicationIif any)
`
`Publication Information:
`
`D Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`I hereby request that the attached application not be published under
`Request Not to PUbIISh.
`m 35 USC. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`T subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`Representative Information:
`
`EFS Web'2.’2.4
`
`

`

`PTOiAIA/M (08-12)
`Approved for use through 01:!311’2014, OMB 0651-0032
`us. Patent and Trademark Office; us. DEPARTMENT OF COMMERCE
`Under the PaperworkReduction Act of 1 995, no per-sons are required to respond to a collectioncfinfiorma-tion unless it contains a valid OMB control number.
`
`
`
`Application Data Sheet 37 CFR 1 76 I Attorney Docket Number
`_ GWLG-Ot'lUS-CIP
`I Application Number
`
`
`Title Of Invention
`
`MEl'l-IOD FOR DIAGNDSING AND MONITORING INFLAMMATORY DISEASE PROGRESSION
`
`
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data, Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below. If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`
`Please SEIBC’E One:
`(I) Customer Number
`‘ 0 US Patent Practitioner
`‘ {3 Limited Recognition (37 CFR 11.9)
`Customer Number
`I 88993
`
`
`
`
`Domestic Benefithational Stage Information:
`
`
`Thissection allows for the applicant to either claim benefit under 35 U.S.C. “11.9(e), “120, 121, or 365(0) or indicate
`National Stage entry from a. PCT application. Providing this. information in the application data-sheet constitutes the
`
`specific reference required by 35 USC. 119(e) or 120, and 37 CFR 1.?8.
`
`
`Prior Application Status
`Pending
`v
`
`Application Number
`Continuity Type,
`Prior Application Number
`Filing Date (WW-.MM-DD)
`
`
`Continuation in part of
`v 15094086
`2016—04-08
`
`
`Prior Application Status
`Expired
`v
`
`Application Number
`Continuity Type
`Prior Application Number
`Filing Date (WW-MM-DD)
`
`
`15094086
`
`Continuation in part of
`
`v PCTI’CAQO'I 41'00074’2
`
`
`
`
`
`
`
`
`
`
`
`
`WEEIBFEEEI.canonStatusvIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII
`
`Application Number
`Continuity Type
`Prior Application Number
`Filing Date (YYW—MM-DD)
`
`
`PCTICA2014IOOOT142
`
`non provisional of
`
`v 61889085
`
`201 31—10-10
`
`Additional Domestic Benefit/National Stage Data may begenerated within this form
`
`byselecting the Add button.
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim benefit of foreign priority and to identify any prior foreign application for which priority is
`not claimed. Providing this information in the application data sheet constitutes the claim for priority as required by 35 'U.S.C. 119(b)
`
`and 37 CFR 1.355(a).
`
`
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`
`Add button.
`
`
`Authorization to Permit Access:
`
`EFS Web'2;2.4
`
`

`

`PTOiAIA/M (OB-12)
`Approved for use through 01:!31l2'014, OMB 0651-0032
`us. Patent and Trademark Office; us. DEPARTMENT OF COMMERCE
`
`Under the PaperworkReduction Act of 1 995, no persons are required to respond to a collectionpfinfiorma-tion unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1 76 I Attorney Docket Number
`_ GWLG-017US-CIP
`'
`I
`I
`I Application Number
`
`
`MEl'l-IOD FOR DIAGNDSING AND MONITORING INFLAMMATORY DISEASE PROGRESSION
`Title Of Invention
`
`
` Authorization to Permit Access to the Instant Application by the Participating Offices
`
`
`
`If checked, theundersigned hereby grantsthe LISPTO authority to providethe European Patent Office (EPO),
`the Japan Patent Office'UPO), the Korean Intellectual Property Office (KIPO), the Worldlnt‘ellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked if the applicant
`does not wish the EPO, .JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is ‘filecl to have access to the instant patent application;
`
`In accordance with 3? CFR 1.14(h)(3). access will be provided to a copyof the instant patent application with respect
`to: 'I) the instant patent application-as-filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)-(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any US. application-as-filed from which benefit is
`sought in the instant patent appiication.
`
`In accordance with 37 CFR 1'.’I 4(c), access may be provided'to information concerning the date of filing this Authorization.
`
`
`
`Applicant Information:
`
`
`Providing assignment information in this section does not substitute forcornpliance with any requirement of part 3 of Title 3? ofCFR
`to have an assignment recorded by the Office.
`
`
`Q 0 Legal Representative under 35 U.S.C. ‘I’I-T Assignee
`
`
`
`
`@ Person who shows sufficient proprietary interest Person to whom the inventor is obligated to assign. ‘0
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`v
`
`
`
`E
`
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom theinventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who isthe applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (aesignee, person to whom the inVentor is obligated to assign, or person who otherwise shoWs sufficient
`proprietary interest) together with one or more joint inventors! then the joint inventor or inventors who are also the applicant should'be
`identified in this sect-ion.
`
`
`Name of the Deceased or Legally lncapacitated Inventor :I
`
`If theAssignee is an Organization check here.
`
`
`
`
`organization Name MCMASTER UNIVERSITY
`
`
`
`EFS Web'2;2.4
`
`

`

`PTOfAlA/M (OB-12)
`Approved for use through 01131112014, OMB 0651-0032
`US. Patent and Trademark Office; U.S. DEPARTMENT’OF COMMERCE
`Under the PaperworkReduction Act of 1 995, no persons are required to respond to a collection.,ofinfiorma~tion unless it contains a valid OMB control number.
`
`GWLG-O17US-CIP
`I Attorney Docket Number
`Application Data Sheet 37 .CFR 1.76 .
`1 Application Number
`
`
`Title of Invention METHOD FOR DIAGNDSING AND MONITORING INFLAMMATORY DISEASE PROGRESSION
`
`
`
`
`
`Mailing Address Information:
`
`Address 1
`175 Longwood Road South
`
`
`
`
`
`Address 2
`
`Suite 305
`
`
`City
`’”iiéi¥iii3ii”””””””””””””””””””””””””””””””””””””” StateiProvmceON’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’
`Country} 1 CA
`Postal Code
`LSPOAt
`Phone Number
`Fax Number
`
`"’E’ifiéiiiiaaié’éé’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’’
`
`
`
`I 44372
`
`Additional Applicant Data may-begenerated within this form by selecting the Add button.
`
`.1
`
`
`Signature:
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33,. See STCFR 1.4 for signature requirements and
`certifications
`
`
`Signature
`[Yin P. Zha‘ng 4.43721
`‘ Date '(YWY~MM—DD)
`2016-06-26
`
`First Name
`Yin Philip
`I Registration Number
`
`
`
`Last Name
`
`
`
`Zhang
`
`Additional Signature. may be generated within this form by selecting theAdd button.
`
`
`This collection of-information is required by 37 CFR 1.78. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 USC. 122 and 37.CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data.
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on theamount of time you requireto
`complete this form and/or suggestions for reducing this burden, should be sent to the. Chief Information Officer, US. Patent and
`Trademark Office, US. Department of Commerce, PO. Box 1450, Alexandria, VA 2231 3-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THISADDRESS. SEND TO: Commissioner for Patents, PO. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web'2.’2.4
`
`

`

`Privacy Act Statement
`
`
`
`
`
`The Privacy'Act of 1974 (P.L. Bit-5%) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuantto‘the requirements of the Act, please be advised‘that:
`(1') the-general authority for the collection
`of this information is 35 U.S'.C. 2‘(b)'(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`if you do not
`furnish the requested information, the US. Patent and Trademarthfice may not be able to process and/or examine your submission, which may-
`result in termination of proceedings or abandonment of the application-or expiration ofthe patent.
`
`The information provided by you in this form will be subject to the‘following routine uses:
`
`1.
`
`The information on this form will be treated confidentiaiiy to the extent allowed under the Freedom of information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`Whether the Freedom of information Act requires'disciosure of these records;
`
`A record from thissystem of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate,.or
`administrative tribunal, including-disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting, a request involvingan
`individual, to whom the. record pertains, when the individual has requested assistance from the Member with respect to thesu'bject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine. use, to a contractor of the Agency having need forthe information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552atm).
`
`A record related to an international Application flied under'the Patent Cooperation Treaty in this system of records may be disclosed,
`as-a routine use, tothe International Bureau of the World intellectual Property Organization, pursuantto the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a'routine use, to an other federal agency fer purposes of National Security
`review-(35 U.S.C. 181);and for review pursuant to the Atomic Energy Act (42 U.S.C. 21B_(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or hisiher designee,
`during an inspection of records conducted by GSA as part of that agency's responsibilityto recommend improvements- in records
`management practices and programs, under authority'of 44 USC. 2904 and 2906‘. Such disclosure shall be madein accordance with the
`GSA regulations governing inspection of records for this Purpose, and any other relevant (i.‘e., GSA or Comm‘erceidirective. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant
`to 35 U,S.C. 12203) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of.37
`CFR 1.14, as a routine use, to the public ifthe record was filed in an application which becameabandoned or in which the proceedings were
`terminated and which application is referenced by'either a published application, an application open to'publi‘c inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`
`EFS Web'2.’2.4
`
`
`
`